These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20374497)

  • 21. Hormone receptor immunoreactivity in hemangioblastomas and clear cell renal cell carcinomas.
    Brown DF; Dababo MA; Hladik CL; Eagan KP; White CL; Rushing EJ
    Mod Pathol; 1998 Jan; 11(1):55-9. PubMed ID: 9556423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metastatic renal cell carcinoma to the bladder: a clinicopathologic and immunohistochemical study.
    Sim SJ; Ro JY; Ordonez NG; Park YW; Kee KH; Ayala AG
    Mod Pathol; 1999 Apr; 12(4):351-5. PubMed ID: 10229498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of spinal cord hemangioblastoma in von Hippel-Lindau disease].
    Nakashima H; Tokunaga K; Tamiya T; Matsumoto K; Ohmoto T; Furuta T
    No Shinkei Geka; 1999 Jun; 27(6):533-40. PubMed ID: 10396736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human telomerase RNA expression and MIB-1 (Ki-67) proliferation index distinguish hemangioblastomas from metastatic renal cell carcinomas.
    Brown DF; Gazdar AF; White CL; Yashima K; Shay JW; Rushing EJ
    J Neuropathol Exp Neurol; 1997 Dec; 56(12):1349-55. PubMed ID: 9413283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of subtypes of metastatic renal-cell carcinoma: correlating findings of fine-needle aspiration biopsy and surgical pathology.
    Mai KT; Alhalouly T; Lamba M; Yazdi HM; Stinson WA
    Diagn Cytopathol; 2003 Feb; 28(2):66-70. PubMed ID: 12561022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal cell carcinoma marker (RCC-Ma) is specific for cutaneous metastasis of renal cell carcinoma.
    Perna AG; Ostler DA; Ivan D; Lazar AJ; Diwan AH; Prieto VG; Reed JA
    J Cutan Pathol; 2007 May; 34(5):381-5. PubMed ID: 17448192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The utility of PAX-2 in distinguishing metastatic clear cell renal cell carcinoma from its morphologic mimics: an immunohistochemical study with comparison to renal cell carcinoma marker.
    Gokden N; Gokden M; Phan DC; McKenney JK
    Am J Surg Pathol; 2008 Oct; 32(10):1462-7. PubMed ID: 18685487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 41-year-old woman with von Hippel-Lindau and a cerebellar lesion.
    Martin SE; Al-Khatib SM; Turner MS; Douglas-Akinwande AC; Hattab EM
    Brain Pathol; 2010 Mar; 20(2):511-4. PubMed ID: 20438472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.
    Zhao C; Bratthauer GL; Barner R; Vang R
    Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CAIX and pax-8 Commonly Immunoreactive in Endolymphatic Sac Tumors: A Clinicopathologic Study of 26 Cases with Differential Considerations for Metastatic Renal Cell Carcinoma in von Hippel-Lindau Patients.
    Thompson LDR; Magliocca KR; Andreasen S; Kiss K; Rooper L; Stelow E; Wenig BM; Bishop JA
    Head Neck Pathol; 2019 Sep; 13(3):355-363. PubMed ID: 30291511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK).
    Wechsel HW; Petri E; Bichler KH; Feil G
    Anticancer Res; 1999; 19(4A):2583-90. PubMed ID: 10470199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD70: a new tumor specific biomarker for renal cell carcinoma.
    Junker K; Hindermann W; von Eggeling F; Diegmann J; Haessler K; Schubert J
    J Urol; 2005 Jun; 173(6):2150-3. PubMed ID: 15879877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PAX8 expression in sporadic hemangioblastoma of the kidney supports a primary renal cell lineage: implications for differential diagnosis.
    Zhao M; Williamson SR; Yu J; Xia W; Li C; Zheng J; Zhu Y; Sun K; Wang Z; Cheng L
    Hum Pathol; 2013 Oct; 44(10):2247-55. PubMed ID: 23849894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
    Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
    Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical distinction of primary adrenal cortical lesions from metastatic clear cell renal cell carcinoma: a study of 248 cases.
    Sangoi AR; Fujiwara M; West RB; Montgomery KD; Bonventre JV; Higgins JP; Rouse RV; Gokden N; McKenney JK
    Am J Surg Pathol; 2011 May; 35(5):678-86. PubMed ID: 21490444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Papillary cystadenoma of the epididymis and broad ligament: morphologic and immunohistochemical overlap with clear cell papillary renal cell carcinoma.
    Cox R; Vang R; Epstein JI
    Am J Surg Pathol; 2014 May; 38(5):713-8. PubMed ID: 24441657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases.
    Taki A; Nakatani Y; Misugi K; Yao M; Nagashima Y
    Mod Pathol; 1999 Mar; 12(3):310-7. PubMed ID: 10102617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue expression and plasma levels of adrenomedullin in renal cancer patients.
    Michelsen J; Thiesson H; Walter S; Ottosen PD; Skøtt O; Jensen BL
    Clin Sci (Lond); 2006 Jul; 111(1):61-70. PubMed ID: 16515534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma.
    Thompson RH; Gillett MD; Cheville JC; Lohse CM; Dong H; Webster WS; Chen L; Zincke H; Blute ML; Leibovich BC; Kwon ED
    Cancer; 2005 Nov; 104(10):2084-91. PubMed ID: 16208700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoreactivity of CD10 and inhibin alpha in differentiating hemangioblastoma of central nervous system from metastatic clear cell renal cell carcinoma.
    Jung SM; Kuo TT
    Mod Pathol; 2005 Jun; 18(6):788-94. PubMed ID: 15578072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.